GSK Gears Up For Three Cancer Launches In 2020
Oncology Pipeline Pivotal To Company’s Future
After selling off its oncology franchise just five years ago, GSK is poised to re-enter the fray - and is preparing its commercial teams for battle.
After selling off its oncology franchise just five years ago, GSK is poised to re-enter the fray - and is preparing its commercial teams for battle.